Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Acceptability of Three Doses of ENG-MIUS vs Copper IUD
NCT00967746Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Nov 2009
- Primary completion
- Nov 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of etonogestrel in contraception, sponsored by Organon & Co.. Started Nov 2009; status: completed.
02
Drugs
etonogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00967746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00967746.